Abstract
Introduction:
The risk of coronavirus disease-19 infection for healthcare professionals and patients in hospitals remains unclear.
Methods:
We investigated whether precautions adopted in our inflammatory bowel disease (IBD) unit have minimized the risks of infection for all patients accessing our facilities in a 1-month period by assessing the rate of coronavirus disease-19 infection in the follow-up period.
Results:
Three hundred-twenty patients with IBD were included. None were infected from severe acute respiratory syndrome-coronavirus 2 in the follow-up period. None of the IBD team members were infected.
Discussion:
Neither pharmacological immunosuppression nor access to the hospital seem to be risk factors for infection in patients with IBD.
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Betacoronavirus / immunology
-
COVID-19
-
COVID-19 Testing
-
Clinical Laboratory Techniques / statistics & numerical data
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / immunology
-
Coronavirus Infections / prevention & control*
-
Follow-Up Studies
-
Health Services Accessibility / statistics & numerical data
-
Hospital Units / statistics & numerical data*
-
Humans
-
Immunosuppressive Agents / adverse effects*
-
Infection Control / statistics & numerical data*
-
Infectious Disease Transmission, Patient-to-Professional / prevention & control
-
Infectious Disease Transmission, Patient-to-Professional / statistics & numerical data
-
Infectious Disease Transmission, Professional-to-Patient / prevention & control
-
Infectious Disease Transmission, Professional-to-Patient / statistics & numerical data
-
Inflammatory Bowel Diseases / drug therapy
-
Inflammatory Bowel Diseases / immunology*
-
Italy / epidemiology
-
Middle Aged
-
Pandemics / prevention & control*
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / immunology
-
Pneumonia, Viral / prevention & control*
-
Risk Factors
-
SARS-CoV-2
-
Young Adult